InvestorsHub Logo
Followers 22
Posts 7075
Boards Moderated 0
Alias Born 05/14/2011

Re: None

Friday, 02/08/2019 4:38:40 AM

Friday, February 08, 2019 4:38:40 AM

Post# of 58863
Only_thing Monty_is_going to_shake_up is our Kool Aid. SSDD (same ship). Only radical change will be IF we get clients signing on in near term.

Within finale section of our song and dance. Well played, actually. Hope springs eternal. Monty comes across like any of us. Good touch for our morale. Our reality will play out together.

Excerpt from yesterday's script with Link to full Transcript here

Unidentified Analyst
If nobody else has any questions, I'll ask one more. I'm not sure you can answer it. You have acquired a new shareholder. And I was wondering if you just had any contact with the company at all, or do you know what his intentions are at this point?

This isn't the last question. Hayward given opportunity, and takes it to go over a couple other issues. Should be read.

James Hayward

Yes, I think actually we have a statement from that shareholder who I have spoken to. And he has authorized me to read it if the question arose, so I'd be happy to actually. It reads:

I am a private investor with nearly four decades of experience. I first learned about Applied DNA sciences in late 2016, and gradually accumulated about 1 million shares, mostly in 2017.

In December of 2018 and January 2019, I bought another approximately 4 million shares and became a 10% beneficial owner.

While I understand and share the pain of my fellow shareholders regarding Applied DNA's dilutive just-in-time capital raise and the negative effect it's had on the stock price, I also appreciate that APDN management runs a very lien cost conscious operation, including relatively low executive compensation, while still making significant and worthwhile R&D investments with enormous long-term potential.

I trust that management has gotten the message of the slumping stock price, as an aside we have, and will improve on their financing strategy. I have become a 10% investor in APDN, because I strongly believe in the enormous long-term growth potential of both DNA tagging and LineaRX, both with vast scale and profit margin potential.

And relative to this potential, this is by far the most undervalued and underappreciated company I've ever invested in. I have no intention whatsoever of being an activist investor. On the contrary, I intend to continue to be supportive of management by being a patient investor with a very long-term horizon.


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent APDN News